Chlorophenoxy aminoalkyl derivatives as histamine H3R ligands and antiseizure agents
- 1 January 2016
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 24 (2), 53-72
- https://doi.org/10.1016/j.bmc.2015.11.021
Abstract
No abstract availableKeywords
Funding Information
- National Science Center (DEC-2011/02/A/NZ4/00031, K/ZDS/004689)
- European GLISTEN (CM1207)
- DFG INST (208/664-1)
This publication has 64 references indexed in Scilit:
- Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuseFrontiers in Systems Neuroscience, 2012
- Several down, a few to go: histamine H3receptor ligands making the final push towards the market?Expert Opinion on Investigational Drugs, 2011
- The histamine H3 receptor: from discovery to clinical trials with pitolisantBritish Journal of Pharmacology, 2011
- In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer’s diseaseNeuropharmacology, 2011
- Histamine Pharmacology and New CNS Drug TargetsCNS Neuroscience & Therapeutics, 2010
- A Simple Quantitative Method for Analyzing Electrographic Status Epilepticus in RatsJournal of Neurophysiology, 2009
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- UCSF Chimera?A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Carboxylic acids and skeletal muscle chloride channel conductance: effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acidIl Farmaco, 2001
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973